JGFCF News Alert Jaguar Financial Cp (JGFCF) 0.0100 02/15/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Jaguar Financial Cp (JGFCF) 0.0100 $JGFCF

Jaguar Updates Equity Interest in Alternative Earth Resources
Newsfile Corp - Fri Jan 23, 4:16PM CST
full story)
AER.VN: 0.070 (+0.005), JFC.VN: 0.015 (unch)

Jaguar Announces Equity Interest in Alternative Earth Resources
Newsfile Corp - Fri Jan 09, 3:31PM CST
full story)
AER.VN: 0.070 (+0.005), JFC.VN: 0.015 (unch)

Jaguar Announces Resumption of Stock Option Plan and Adoption of Advance Notice By-Law
Newsfile Corp - Wed Dec 10, 3:31PM CST
full story)
JFC.VN: 0.015 (unch)

Purchase of Additional Shares of Jaguar
Newsfile Corp - Fri Nov 28, 12:39PM CST
full story)

Jaguar Announces Normal Course Issuer Bid
Newsfile Corp - Fri Nov 21, 3:31PM CST
full story)
JFC.VN: 0.015 (unch)

Jaguar Announces Equity Interest in Galway Metals
Newsfile Corp - Tue Nov 04, 3:30PM CST
full story)
JFC.VN: 0.015 (unch)

Galway Metals Inc. Announces Dismissal of Application to BCSC for Review of TSXV Approval of Financing
Marketwire - Thu Aug 21, 12:46PM CDT
Galway Metals Inc. (TSX VENTURE: GWM) (the "Company" announces that the British Columbia Securities Commission dismissed the application of Jaguar Financial Corporation for a hearing and review of the decision of the TSX Venture Exchange to approve the Company's private placement that closed on April 16, 2014 (see the Company's press release of May 20, 2014).
GWM.VN: 0.120 (-0.010)

Jaguar Announces Investment in Added Capital Inc. and Change of Auditor
Newsfile Corp - Wed Aug 20, 7:57AM CDT
full story)
JFC.VN: 0.015 (unch), AAD.VN: 0.035 (unch)

Jaguar Announces Results of Annual General Meeting
Newsfile Corp - Wed Jun 25, 4:41PM CDT
full story)
JFC.VN: 0.015 (unch)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading